Log In
Print
BCIQ
Print
Print this Print this
 

Dafiro, Exforge, amlodipine/valsartan

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionCombination of the calcium channel blocker amlodipine and the angiotensin receptor blocker valsartan
Molecular Target Angiotensin II type 1 (AT1) receptor (AGTR1) ; Calcium channel
Mechanism of ActionAngiotensin II type 1 (AT1) receptor antagonist; Calcium channel blocker
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationHypertension
Indication DetailsTreat hypertension; Treat hypertension as a first-line therapy
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today